...
机译:P2.01-057肿瘤浸润淋巴细胞与完全切除阶段肺腺癌的EGFR突变结合定量术语(N2)肺腺癌
Radiation Oncology Shanghai Chest Hospital Shanghai Jiao Tong University;
Radiation Oncology Shanghai Chest Hospital Shanghai Jiao Tong University;
Radiation Oncology Shanghai Chest Hospital Shanghai Jiao Tong University;
Radiation Oncology Shanghai Chest Hospital Shanghai Jiao Tong University;
Department of Pathology Fudan University Shanghai Cancer Center;
Department of Pathology Fudan University Shanghai Cancer Center;
机译:P2.01-057肿瘤浸润淋巴细胞与完全切除阶段肺腺癌的EGFR突变结合定量术语(N2)肺腺癌
机译:JCES 01.10完全切除阶段II-IIIa的主要治疗失败模式(N1-N2)EGFR-突变阳性肺癌
机译:P2.03-047完全切除阶段II-IIIa(N1-N2)EGFR-突变阳性肺癌的主要治疗失败模式
机译:肺腺癌肿瘤浸润淋巴细胞的紧凑性测量与整体患者存活和免疫分数有关
机译:肿瘤浸润淋巴细胞对IIIA(N2)期非小细胞肺癌完全切除患者的预后价值
机译:肿瘤浸润淋巴细胞对完全切除阶段IIIa(N2)非小细胞肺癌患者的预后价值